Advances in osteosarcoma

I Panez-Toro, J Muñoz-García… - Current osteoporosis …, 2023 - Springer
Abstract Purpose of Review This article gives a brief overview of the most recent
developments in osteosarcoma treatment, including targeting of signaling pathways …

Osteosarcoma: time to move on?

SS Bielack - European journal of cancer, 2010 - ejcancer.com
Osteosarcoma treatment follows very simple rules: if you want a cure, cut out all detectable
tumour and poison invisible tumour cells with as much chemotherapy as the patient can …

Pathogenesis and current treatment of osteosarcoma: perspectives for future therapies

R Rathore, BA Van Tine - Journal of clinical medicine, 2021 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumor in children and young
adults. The standard-of-care curative treatment for osteosarcoma utilizes doxorubicin …

Origin and therapies of osteosarcoma

B Moukengue, M Lallier, L Marchandet, M Baud'huin… - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcoma is the most common malignant bone tumor in children, with
a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the …

Therapy for osteosarcoma: where do we go from here?

AJ Chou, DS Geller, R Gorlick - Pediatric Drugs, 2008 - Springer
Osteosarcoma is the most common malignant primary bone tumor in children and
adolescents. Current optimal treatment for osteosarcoma consists of multi-agent …

[HTML][HTML] Advances in targeted therapy for osteosarcoma

W Zhou, M Hao, X Du, K Chen, G Wang… - Discovery …, 2014 - discoverymedicine.com
Osteosarcoma is an aggressive cancer in skeletal system with unknown molecular
mechanisms of etiology and pathogenesis, therefore it remains a challenge for current …

Advances in bone‐targeted drug delivery systems for neoadjuvant chemotherapy for osteosarcoma

C Li, X Liu, L Zhang, L Chen, X Shi, S Wu… - Orthopaedic …, 2016 - Wiley Online Library
Targeted therapy for osteosarcoma includes organ, cell and molecular biological targeting;
of these, organ targeting is the most mature. Bone‐targeted drug delivery systems are used …

Current strategies of chemotherapy in osteosarcoma

D Carrle, SS Bielack - International orthopaedics, 2006 - Springer
Osteosarcoma, the most common type of primary malignant tumour that develops in bone,
can be classified into several different sub-types. While the majority of osteosarcomas are …

Innovative approaches for treatment of osteosarcoma

E Rothzerg, AL Pfaff, S Koks - Experimental Biology and …, 2022 - journals.sagepub.com
Osteosarcoma (OS) is the most common primary malignant bone tumor, which usually
occurs in children and adolescents. It is generally a high-grade malignancy presenting with …

Novel insights and therapeutic interventions for pediatric osteosarcoma

L Kager, G Tamamyan, S Bielack - Future Oncology, 2016 - Taylor & Francis
High-grade osteosarcomas are the most common primary malignant tumors of bone. With
complete surgical resection and multi-agent chemotherapy up to 70% of patients with high …